drugs controller general of india
Health Matters | Gang Wars & Power Games – Two Biggest Challenges the New DCGI Must Deal With
WHO Alert on Cough Syrups 'Alarming', There Are Missing Links That Need to Be Probed: Expert
Panel Under Drug Regulator to Meet Soon to Decide Ban on Cocktail Meds, Codeine-based Cough Syrups
Zydus Cadila to Submit Additional Data on its Covid-19 Vaccine to DCGI on Friday
Developed by DRDO, First Batch of Anti-Covid Drug 2DG Released. Here's How it Works
Dr Reddy's Begins Process for Emergency Use Authorisation of Russian Covid-19 Vaccine Sputnik V
Insistence on Indemnity, Storage Issue: Why Decision on Pfizer's Emergency Use Application is Not Easy
DCGI and Institutional Ethics Committee Investigating Claim of Adverse Event in Covid Vaccine Trial: Officials
Bharat Biotech Plans to Launch Vaccine Candidate in Second Quarter of 2021 after Nod from Regulator
Drug Body Approves Commercial Launch of Low Cost Covid-19 Test 'Feluda'
Abbott Gets DCGI Nod for Once-a-day Heart Failure & Angina Treatment Drug
Covid-19: Serum Institute of India Gets Nod for Phase 2, 3 Clinical Trials of Oxford Vaccine Candidate on Adults
Despite DGCI Nod, Health Ministry Decides against Including Itolizumab for Treatment of Covid-19
AIIMS Panel Gives Nod to Human Clinical Trial of Covaxin, Volunteer Enrolment to Start on Monday
Biocon's Itolizumab Reducing Covid-19 Mortality in Cuba Gets Approval in India: Kiran Mazumdar Shaw
Biocon to Launch Drug For Covid-19 Patients; Priced at Rs 8,000 Per Vial
DCGI Asks Manufacturers to Take Steps to Prevent Black-marketing, Overpricing of Covid-19 Drugs
AstraZeneca's Dapagliflozin Gets DCGI Nod for Treatment of Heart Failure Patients
India Approves Gilead's Antiviral Drug Remdesivir to Treat Severe Covid-19 Cases
Biocon Gets DCGI Nod for Device to Treat Critical Covid-19 Patients
